The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Oxaliplatin 5mg/ml Concentrate for Solution for Infusion

5 milligram(s)/millilitre Concentrate for solution for infusion

Fresenius Kabi Deutschland GmbHPA2059/049/001

Main Information

Trade NameOxaliplatin 5mg/ml Concentrate for Solution for Infusion
Active SubstancesOxaliplatin
Strength5 milligram(s)/millilitre
Dosage FormConcentrate for solution for infusion
Licence HolderFresenius Kabi Deutschland GmbH
Licence NumberPA2059/049/001

Group Information

ATC CodeL01XA Platinum compounds
L01XA03 oxaliplatin

Status

Authorised/WithdrawnAuthorised
Licence Issued24/07/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back